Nitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner

Diabetes

Volumn 63, Issue 1, 2014, Pages 272-281

  Bir, Shyamal C ^a   Pattillo, Christopher B ^a   Pardue, Sibile ^a   Kolluru, Gopi K ^a   Shen, Xinggui ^a   Giordano, Tony ^b   Kevil, Christopher G ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b TheraVasc Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; S NITROSOTHIOL; SODIUM NITRATE; SODIUM NITRITE; TRIACYLGLYCEROL; VASCULOTROPIN; XANTHINE OXIDASE; NITRIC ACID DERIVATIVE; VASCULOTROPIN A;

AGE; AGED; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BIOAVAILABILITY; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMORAL ARTERY; GASTROCNEMIUS MUSCLE; LIMB BLOOD FLOW; LIMB INJURY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; REVASCULARIZATION; STEADY STATE; TISSUE INJURY; TISSUE NECROSIS; TISSUE REPAIR; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR TISSUE; ANIMAL; COMPLICATION; DRUG EFFECTS; HINDLIMB; ISCHEMIA; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; TIME; VASCULARIZATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; FEMORAL ARTERY; HINDLIMB; ISCHEMIA; MICE; NEOVASCULARIZATION, PATHOLOGIC; NITRATES; NITRIC OXIDE; SODIUM NITRITE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891792832     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0890     Document Type: Article

References (38)

1. Aronow WS. Peripheral arterial disease in the elderly. Clin Interv Aging 2007;2:645-654
2. Mukherjee D. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2009;23:335-345
3. Schaper NC, Nabuurs-Franssen MH, Huijberts MS. Peripheral vascular disease and type 2 diabetes mellitus. Diabetes Metab Res Rev 2000;16 (Suppl. 1):S11-S15
4. Tirziu D, Simons M. Angiogenesis in the human heart: gene and cell therapy. Angiogenesis 2005;8:241-251
5. Milkiewicz M, Ispanovic E, Doyle JL, Haas TL. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 2006;38:333-357
6. Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999;154:355-363
7. Abaci A, Oǧuzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-2242
8. Bir SC, Fujita M, Marui A, et al. New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. Circ J 2008;72:633-640
9. Suuronen EJ, Hazra S, Zhang P, et al. Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation. J Thorac Cardiovasc Surg 2010;139:209-216.e202
10. Reed MJ, Edelberg JM. Impaired angiogenesis in the aged. Sci Aging Knowledge Environ 2004;2004:pe7
11. Hoffmann J, Haendeler J, Aicher A, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001;89:709-715
12. Ruiter MS, van Golde JM, Schaper NC, Stehouwer CD, Huijberts MS. Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin Sci (Lond) 2010;119:225-238
13. Allen JD, Miller EM, Schwark E, Robbins JL, Duscha BD, Annex BH. Plasma nitrite response and arterial reactivity differentiate vascular health and performance. Nitric Oxide 2009;20:231-237
14. Kumar D, Branch BG, Pattillo CB, et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci USA 2008;105:7540-7545
15. Pattillo CB, Bir SC, Branch BG, et al. Dipyridamole reverses peripheral ischemia and induces angiogenesis in the db/db diabetic mouse hind-limb model by decreasing oxidative stress. Free Radic Biol Med 2011;50:262-269
16. Venkatesh PK, Pattillo CB, Branch B, et al. Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxidedependent pathway. Cardiovasc Res 2010;85:661-670
17. Kevil CG, Kolluru GK, Pattillo CB, Giordano T. Inorganic nitrite therapy: historical perspective and future directions. Free Radic Biol Med 2011;51: 576-593
18. Cohen RA, Tong X. Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol 2010;55: 308-316
19. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446-1454
20. Elrod JW, Calvert JW, Gundewar S, Bryan NS, Lefer DJ. Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide. Proc Natl Acad Sci USA 2008;105:11430-11435
21. Montenegro MF, Amaral JH, Pinheiro LC, et al. Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension. Free Radic Biol Med 2011;51:144-152
22. Tousoulis D, Briasoulis A, Papageorgiou N, et al. Oxidative stress and endothelial function: therapeutic interventions. Recent Pat Cardiovasc Drug Discov 2011;6:103-114
23. Kuwabara M, Kakinuma Y, Ando M, et al. Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. J Physiol Sci 2006;56:95-101
24. Bir SC, Kolluru GK, McCarthy P, et al. Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1a and vascular endothelial growth factor-dependent angiogenesis. J Am Heart Assoc 2012;1: e004093
25. Steinberger J, Daniels SR; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young); American Heart Association Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448-1453
26. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001;49:507-521
27. Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012;2012:918267
28. Emanueli C, Monopoli A, Kraenkel N, et al. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice. Br J Pharmacol 2007;150:873-882
29. Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ Res 2007;101:948-956
30. Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 2007;56:656-665
31. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998;101: 2567-2578
32. Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol 2005;25:1603-1609
33. Miller JW, Le Couter J, Strauss EC, Ferrara N. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 2013;120:106-114
34. Li Q, Verma A, Han PY, et al. Diabetic eNOS-knockout mice develop accelerated retinopathy. Invest Ophthalmol Vis Sci 2010;51:5240-5246
35. Cantu-Medellin N, Kelley EE. Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: Insights regarding where, when and how. Nitric Oxide 2013;34:19-26
36. Weitzberg E, Lundberg JO. Novel aspects of dietary nitrate and human health. Annu Rev Nutr 2013;33:129-159
37. Gilchrist M, Winyard PG, Aizawa K, Anning C, Shore A, Benjamin N. Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic Biol Med 2013;60:89-97
38. Mohler ER III, Hiatt WR, Gornik HL, et al. Benefit of sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function. Vasc Med. In press